Anzeige
Mehr »
Login
Samstag, 21.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
20.12.24
08:11 Uhr
6,650 Euro
+0,050
+0,76 %
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,8507,05013:04
6,7507,10020.12.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoLifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 20251
DoLifecore Biomedical to Provide CDMO Services to Nirsum Labs1
DoLifecore unterstützt Nirsums Phase-2-Studie für Opioid-Behandlung1
DoLifecore to support Nirsum's phase 2 opioid treatment trial1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
DoLifecore Biomedical, Inc.: Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment1
12.12.Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR)1
26.11.Lifecore extends credit terms, simplifies interest rates1
26.11.Lifecore Biomedical, Inc.: Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO2
21.11.Lifecore Biomedical, Inc.: Lifecore Biomedical Hosts Virtual Investor Day2
21.11.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
15.11.Here's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)2
08.11.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
07.11.Lifecore Biomedical, Inc.: Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 20241
04.11.Lifecore Biomedical Makes Leadership Appointments1
04.11.Lifecore Biomedical, Inc.: Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations1
11.10.Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M1
10.10.LIFECORE BIOMEDICAL, INC. \DE\ - S-8, Securities to be offered to employees in employee benefit plans2
10.10.LIFECORE BIOMEDICAL, INC. \DE\ - S-1, General form for registration of securities2
08.10.Research Analysts Issue Forecasts for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR)5
07.10.Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results2
Seite:  Weiter >>
73 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1